Lucus Advisors’s Chemours CC Stock Holding History

Lucus Advisors’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-6,899	Closed	-$349K	–	208
2017 Q3	$349K	Sell	6,899 -3,162	-31%	-$149K	0.49%	69
2017 Q2	$382K	Buy	+10,061	New	+$397K	0.51%	7

Other funds holding CC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Lucus Advisors's CC Position: Q4 2017 in Review

Lucus Advisors sold out of Chemours (CC) in Q4 2017, closing a stake of 6,899 shares — an estimated $349K sold.

Lucus Advisors first reported a position in CC in Q2 2017 and held it in 2 quarters. The position peaked at $382K in Q2 2017. 538 funds tracked by Wall St. Rank hold CC as of Q4 2017.

Lucus Advisors reported no remaining Chemours position as of Q4 2017 after selling out during the quarter.
Lucus Advisors sold 6,899 Chemours shares in Q4 2017, an estimated $349K.
Lucus Advisors first reported a position in Chemours in Q2 2017 and held it in 2 quarters.
Lucus Advisors's Chemours position peaked at $382K in Q2 2017.
538 funds tracked by Wall St. Rank held Chemours as of Q4 2017.

Based on Lucus Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.